IUCrJ, published by the International Union of Crystallography, is a leading open-access journal dedicated to advancing knowledge in the fields of Biochemistry, Chemistry, Condensed Matter Physics, and Materials Science. Since its inception in 2014, IUCrJ has quickly established itself as a prestigious platform for high-quality research, achieving a remarkable record as a Q1 journal across its categories in 2023. With an increasing impact in the scientific community, evidenced by impressive Scopus rankings, IUCrJ offers unparalleled access to groundbreaking discoveries and methodologies that contribute to the understanding and application of crystallography in various disciplines. The journal’s commitment to open access ensures that research is readily available to a global audience, fostering collaboration and innovation in the scientific community. IUCrJ is an essential resource for researchers, professionals, and students aiming to stay at the forefront of crystallographic research and its interdisciplinary applications.

Annual Review of Biochemistry is a premier publication in the field of biochemistry, renowned for its comprehensive and critical reviews that collate significant advancements and insights since its inception in 1946. Published by Annual Reviews in the United States, this journal maintains a prestigious position within the academic community, boasting a Q1 ranking in the biochemistry category for 2023, with an impressive Scopus rank of #4 out of 438, placing it in the top 1% of its field. With a commitment to excellence, it serves as an essential resource for researchers, professionals, and students striving to stay at the forefront of biochemical research. While the journal does not operate on an open-access model, it continues to provide key insights and knowledge that fuel innovation and discovery in the life sciences. As it converges research from various eras up to 2024, Annual Review of Biochemistry remains a vital contributor to the development of molecular biology and genetics, catering to the needs of a diverse readership keen on advancing their understanding and expertise in biochemistry.

Current Research in Structural Biology, published by Elsevier, is a pioneering Open Access journal that has rapidly gained prominence since its inception in 2019. With a focus on advancing the understanding of molecular and structural biology, this journal provides a platform for researchers and professionals to publish groundbreaking findings that contribute to the field's ongoing development. With a commendable Q2 ranking in both Molecular Biology and Structural Biology categories for 2023, it serves as a vital resource for the community, ensuring accessibility to high-quality research. The journal is indexed in Scopus, showcasing its significant impact and relevance, particularly with a ranking of #26/49 in the Structural Biology discipline. Located in the heart of the Netherlands, Current Research in Structural Biology not only fosters academic discourse but also encourages collaborative research efforts in addressing critical biological questions. Whether you are a researcher, student, or industry professional, this journal is essential for staying abreast of the latest advancements and trends in structural biology.

FEBS LETTERS, published by Wiley, is a prestigious journal that has firmly established its place in the fields of biochemistry, biophysics, genetics, molecular biology, cell biology, and structural biology. With an esteemed history dating back to 1968, this journal continues to be a vital resource for researchers and professionals involved in the biological sciences. It boasts impressive quartile rankings, including Q1 statuses in several categories such as Biochemistry and Genetics, reflecting its high impact factor and significant contribution to scientific discourse. FEBS LETTERS provides a platform for innovative findings and critical reviews, fostering the exchange of knowledge and ideas within the scientific community. Although it operates under a subscription model, the journal ensures broad dissemination of groundbreaking research through its rigorous peer-review process. The vibrant discussions encouraged by articles published in FEBS LETTERS aim to inspire current and future generations of scientists to push the boundaries of biological understanding, making it an indispensable resource for anyone dedicated to advancing their knowledge in these dynamic fields.

PROTEIN SCIENCE, published by Wiley, is a premier journal dedicated to the field of biochemistry, molecular biology, and medicine, boasting an impressive impact factor that reflects its influence and importance within the academic community. Established in 1992, the journal has continuously provided a platform for high-quality research, with a current classification in the top quartile (Q1) for its critical contributions to the understanding of protein structure and function, as well as its applications in health and disease. With a Scopus ranking placing it in the 91st percentile among its peers, PROTEIN SCIENCE publishes cutting-edge studies and reviews that are essential for researchers, professionals, and students seeking to advance their knowledge in protein research. Although it does not currently offer open access options, the journal remains dedicated to disseminating vital findings that support the ongoing advancements in molecular biology and biochemistry. Researchers can count on PROTEIN SCIENCE for consistently rigorous peer-reviewed content that fosters meaningful dialog and innovation in the life sciences.

NATURE STRUCTURAL & MOLECULAR BIOLOGY is a leading journal published by NATURE PORTFOLIO, dedicated to advancing the field of molecular and structural biology since its inception in 1998. With an impressive impact factor that places it in the Q1 quartile across both the Molecular Biology and Structural Biology categories, this journal is pivotal for researchers and professionals seeking to publish innovative and high-impact results. Its Scopus ranking further highlights its elite status, with a remarkable 98th percentile for Structural Biology and 95th for Molecular Biology. While the journal does not currently offer open access, it continues to foster a rich discourse among scientists by providing a platform for the dissemination of groundbreaking research. Located in the United Kingdom and operated from Berlin, the journal's commitment to excellence positions it as an indispensable resource for students, researchers, and practitioners in the realms of biochemistry, genetics, and molecular biology.

CURRENT OPINION IN STRUCTURAL BIOLOGY is a premier journal published by CURRENT BIOLOGY LTD that serves as a critical platform for disseminating comprehensive reviews and the latest insights into the field of structural biology. With an impressive impact factor and ranked in the top quartile (Q1) in both Molecular Biology and Structural Biology categories, this journal exemplifies excellence in its scope and academic rigor. Researchers and professionals benefit from its insightful articles that cover cutting-edge developments, methodological advancements, and the implications of structural biology in various biological contexts. As part of the esteemed Current Biology series, the journal is committed to enriching the scientific community's understanding of biomolecular structures and their functions. Based in the United Kingdom and indexed in Scopus with high rankings in multiple relevant fields, CURRENT OPINION IN STRUCTURAL BIOLOGY remains an essential resource for scholars at every stage of their academic journey, from students to seasoned researchers, ensuring the ongoing progress of knowledge in this dynamic field.

FEBS Open Bio is a leading open-access journal published by Wiley, dedicated to advancing our understanding of biochemistry, genetics, and molecular biology. Since its inception in 2011, this journal has provided a robust platform for researchers to share their findings with a wider audience, ensuring the dissemination of high-quality scientific knowledge. With an impact factor reflecting its stature in its field, FEBS Open Bio is ranked #77 out of 221 in general biochemistry, genetics, and molecular biology, placing it in the 65th percentile among its peers. This journal serves as an essential resource for professionals, researchers, and students alike, fostering collaboration and innovation within the scientific community. The commitment to open access not only enhances visibility but also promotes transparency in research, making it a vital contributor to the ongoing dialogue in biochemical and molecular biological sciences. For those looking to stay at the forefront of research developments, FEBS Open Bio is a key publication addressing the latest trends and discoveries in the field.

Acta Crystallographica Section D - Structural Biology is a premier academic journal published by the International Union of Crystallography, dedicated to advancing the field of structural biology. With an ISSN and E-ISSN of 2059-7983, this journal plays a crucial role in disseminating high-quality research, covering a wide spectrum of topics including crystallography, macromolecular structures, and their biological implications. Operating under a Q2 category ranking in the realm of structural biology, it highlights innovative and transformative studies that enhance our understanding of molecular architecture. The journal is notably indexed in Scopus, where it holds a rank of #28/49 in its category, placing it in the 43rd percentile. This robust positioning underscores its significance to the research community. With a reader base that includes leading scientists, professionals, and students in the biosciences, Acta Crystallographica Section D is integral for those looking to stay updated on cutting-edge discoveries in structural biology. The journal is available for readership and serves as a pivotal platform for researchers aiming to share their findings and contribute to the scientific dialogue.

PROTEIN AND PEPTIDE LETTERS is a prominent peer-reviewed journal published by Bentham Science Publishers Ltd, specializing in the dynamic fields of biochemistry and structural biology. With an ISSN of 0929-8665 and a corresponding E-ISSN of 1875-5305, the journal has been a pivotal platform for researchers since its inception in 1994. Spanning various aspects of protein and peptide research, it aims to disseminate groundbreaking findings that enhance our understanding of molecular mechanisms and therapeutic applications. Although categorized in the Q3 quartile for biochemistry and medicine, and Q4 in structural biology within the 2023 metrics, it remains a valuable resource in the academic arena, offering insight into the latest research and advancements. As the journal converges towards its 2024 milestone, it continues to reflect the evolving landscape of molecular research. While it currently does not offer open access, the accessibility to its impactful content is essential for students, professionals, and researchers invested in these critical scientific disciplines.